Budget Amount *help |
¥47,710,000 (Direct Cost: ¥36,700,000、Indirect Cost: ¥11,010,000)
Fiscal Year 2012: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2011: ¥14,300,000 (Direct Cost: ¥11,000,000、Indirect Cost: ¥3,300,000)
Fiscal Year 2010: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2009: ¥21,060,000 (Direct Cost: ¥16,200,000、Indirect Cost: ¥4,860,000)
|
Research Abstract |
Overexpression of Sox9 in articular chondrocytes resulted in delay of osteoarthritis change. In addition, genome-wide screening using GeneChip with chondrocytes derived mouse articular cartialge, Sox9-EGFP mice, and Sox9-EGFP null chimera identified one gene involved in osteoarthritis and one gene induced by Sox9. Furthermore, screening of about 10000 chemical reagents using Sox9-EGFP chondrocytes revealed 7 chemical reagents which has Sox9-indecing activity.
|